These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 15788980
1. How to use the C-reactive protein in cardiac disease? Ursella S, Mazzone M, Portale G, Testa A, Pignataro G, Covino M, Fenici P, Gasbarrini GB, Gentiloni Silveri N. Minerva Cardioangiol; 2005 Feb; 53(1):59-68. PubMed ID: 15788980 [Abstract] [Full Text] [Related]
2. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA. Am J Cardiol; 2007 Jan 01; 99(1):31-5. PubMed ID: 17196457 [Abstract] [Full Text] [Related]
3. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S, Ridker PM. Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935 [Abstract] [Full Text] [Related]
4. C-reactive protein: a novel marker of cardiovascular risk. Shah SH, Newby LK. Cardiol Rev; 2003 Jan 16; 11(4):169-79. PubMed ID: 12852794 [Abstract] [Full Text] [Related]
5. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Karha J, Bavry AA, Rajagopal V, Henderson MR, Ellis SG, Brener SJ. Am J Cardiol; 2006 Sep 01; 98(5):616-8. PubMed ID: 16923447 [Abstract] [Full Text] [Related]
6. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes? Correia LC, Lima JC, Rocha MS, D'Oliveira Junior A, Péricles Esteves J. Clin Chim Acta; 2007 Jan 01; 375(1-2):124-8. PubMed ID: 16916502 [Abstract] [Full Text] [Related]
7. C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes. Abbate A, Biondi-Zoccai GG, Brugaletta S, Liuzzo G, Biasucci LM. Semin Vasc Med; 2003 Nov 01; 3(4):375-84. PubMed ID: 15199444 [Abstract] [Full Text] [Related]
8. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris]. Tanaka H, Tsurumi Y, Kasanuki H. J Cardiol; 2006 Apr 01; 47(4):173-9. PubMed ID: 16637251 [Abstract] [Full Text] [Related]
9. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. Biasucci LM, Liuzzo G, Colizzi C, Rizzello V. Ital Heart J; 2001 Mar 01; 2(3):164-71. PubMed ID: 11305527 [Abstract] [Full Text] [Related]
10. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris. Doo YC, Han SJ, Lee JH, Cho GY, Hong KS, Han KR, Lee NH, Oh DJ, Ryu KH, Rhim CY, Lee KH, Lee Y. Am J Cardiol; 2004 Mar 01; 93(5):554-8. PubMed ID: 14996578 [Abstract] [Full Text] [Related]
11. [Predictive value of the markers of inflammation in acute coronary syndromes]. Ben Khalfallah A, Sanaa I, Annabi N, Ousji M, Aloui H, Naffeti S. Arch Mal Coeur Vaiss; 2005 Sep 01; 98(9):899-905. PubMed ID: 16231577 [Abstract] [Full Text] [Related]
12. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F. J Cardiovasc Med (Hagerstown); 2007 Apr 01; 8(4):293-9. PubMed ID: 17413310 [Abstract] [Full Text] [Related]
13. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile? Koenig W. Ital Heart J; 2001 Mar 01; 2(3):157-63. PubMed ID: 11305526 [Abstract] [Full Text] [Related]
14. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation. Apetrei E, Ciobanu-Jurcuţ R, Rugină M, Gavrilă A, Uscătescu V. Rom J Intern Med; 2004 Mar 01; 42(1):95-102. PubMed ID: 15529598 [Abstract] [Full Text] [Related]
15. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM. J Am Coll Cardiol; 2008 Jun 17; 51(24):2339-46. PubMed ID: 18549920 [Abstract] [Full Text] [Related]
16. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Kones R. Ther Adv Cardiovasc Dis; 2009 Aug 17; 3(4):309-15. PubMed ID: 19460829 [Abstract] [Full Text] [Related]
17. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Li JJ, Fang CH. Med Hypotheses; 2004 Aug 17; 62(4):499-506. PubMed ID: 15050096 [Abstract] [Full Text] [Related]
18. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Wilson AM, Ryan MC, Boyle AJ. Int J Cardiol; 2006 Jan 26; 106(3):291-7. PubMed ID: 16337036 [Abstract] [Full Text] [Related]
19. [Inflammation markers in acute coronary syndrome]. Mirat J, Raguz M, Romić Z, Bergovec M, Raos V, Sikić-Vagić J, Bergovec M. Acta Med Croatica; 2004 Jan 26; 58(2):115-7. PubMed ID: 15208795 [Abstract] [Full Text] [Related]
20. C-reactive protein increase in unstable coronary disease cause or effect? De Servi S, Mariani M, Mariani G, Mazzone A. J Am Coll Cardiol; 2005 Oct 18; 46(8):1496-502. PubMed ID: 16226174 [Abstract] [Full Text] [Related] Page: [Next] [New Search]